Clinical Trials Browser

Phase 1/2 × Untreated Advanced Non-small Cell Lung Cancer × Clear all

NCT06136910 2023-11-18

Oncorine (H101) Combined With Tislelizumab and Chemotherapy in Previously Untreated Advanced Non-small Cell Lung Cancer

Phase 1/2 Unknown

Untreated Advanced Non-small Cell Lung Cancer